Autor: |
Hitoshi Honma, Sae Takahashi, Jun Sada, Hiroaki Somiya, Hiromitsu Mori, Taichiro Muto, Yoshinori Ito, Akihisa Okumura |
Jazyk: |
angličtina |
Rok vydání: |
2024 |
Předmět: |
|
Zdroj: |
BMC Pediatrics, Vol 24, Iss 1, Pp 1-7 (2024) |
Druh dokumentu: |
article |
ISSN: |
1471-2431 |
DOI: |
10.1186/s12887-024-05100-7 |
Popis: |
Abstract Background This study aimed to clarify serum salicylic acid (SA) levels in patients with Kawasaki disease (KD) after the administration of moderate-dose acetylsalicylic acid (ASA) and their relationship with the therapeutic effect. Methods We retrospectively analyzed the clinical data of 142 children with KD. We measured serum SA trough levels during the acute and recovery periods and determined their relationship with clinical and laboratory parameters. Results The median age of patients was 2.4 years. Thirty-one patients had incomplete KD, 29 were intravenous immunoglobulin (IVIG) non-responders, and one patient had coronary artery lesions. The median ASA dose was 49.7 mg/kg/day. The median serum SA level was 22 µg/mL in the acute period and 15 µg/mL in the recovery period, with 45 (33%) in the acute period and 60 (44%) in the recovery period below the limit of measurement ( |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|